Approval of Multispot HIV-1 / HIV-2 Rapid Test
The Food and Drug Administration (FDA) has approved a marketing application (PMA) for the Multispot HIV-1/HIV-2 Rapid Test. This device is indicated for the detection and differentiation of circulating antibodies associated with HIV-1 and HIV-2 in human plasma and serum, as an aid in the diagnosis of infection with HIV-1 and/or HIV-2.
The test is manufactured by Bio-Rad Laboratories, Redmond, WA.
HIV/AIDS Program Director
Office of Special Health Issues
Food and Drug Administration